{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:08:42Z","timestamp":1794618522123,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,13]],"date-time":"2027-07-13T00:00:00Z","timestamp":1815436800000},"content-version":"am","delay-in-days":193,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"The Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005355","name":"American Australian Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008227","name":"Achievement Rewards for College Scientists Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.biomaterials.2026.124429","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:42:07Z","timestamp":1783600927000},"page":"124429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering"],"prefix":"10.1016","volume":"336","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2632-7578","authenticated-orcid":false,"given":"Milan","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-6485","authenticated-orcid":false,"given":"Emily","family":"Ariail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-0869","authenticated-orcid":false,"given":"Sydney R.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Antov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Cozzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0036-4958","authenticated-orcid":false,"given":"Melvin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3337-4257","authenticated-orcid":false,"given":"Dizhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4578-0204","authenticated-orcid":false,"given":"Jordan","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2003-3496","authenticated-orcid":false,"given":"Matthew","family":"Mullaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1995-7888","authenticated-orcid":false,"given":"Gavin","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tza-Huei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4176-3808","authenticated-orcid":false,"given":"Jordan G.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-2776","authenticated-orcid":false,"given":"Jonathan P.","family":"Schneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-3732","authenticated-orcid":false,"given":"Jamie B.","family":"Spangler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-9988","authenticated-orcid":false,"given":"Hai-Quan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124429_bib1","first-page":"235","article-title":"T cells in health and disease, signal transduct","volume":"8","author":"Sun","year":"2023","journal-title":"Target. Ther."},{"key":"10.1016\/j.biomaterials.2026.124429_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002555","article-title":"Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies","volume":"9","author":"Tantalo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124429_bib3","first-page":"1507","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia, N. Engl","volume":"371","author":"Maude","year":"2014","journal-title":"J. Med."},{"key":"10.1016\/j.biomaterials.2026.124429_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice,","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124429_bib5","first-page":"210","article-title":"Lady Espinosa-Aroca, K. Fidyt, V. Mulens-Arias, M. Diaz-Beya, M. Juan, \u00c1. Urbano-Ispizua, J. Esteve, T. Velasco-Hernandez, P. Men\u00e9ndez, CAR-T cell therapy for cancer: current challenges and future directions, Signal Transduct","volume":"10","author":"Zugasti","year":"2025","journal-title":"Target. Ther."},{"key":"10.1016\/j.biomaterials.2026.124429_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1141","article-title":"Engineering chimeric antigen receptor T cells for solid tumour therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124429_bib7","first-page":"3","article-title":"Generation of CAR-T cells by lentiviral transduction","author":"Okuma","year":"2021","journal-title":"Methods Mol. Biol. Clifton NJ 2312"},{"key":"10.1016\/j.biomaterials.2026.124429_bib8","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ymthe.2025.02.031","article-title":"Presetting CAR-T cells during ex vivo biomanufacturing","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2026.124429_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105266","article-title":"Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment","volume":"106","author":"Bui","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biomaterials.2026.124429_bib10","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.7150\/thno.77259","article-title":"Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging","volume":"12","author":"Jung","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124429_bib11","doi-asserted-by":"crossref","first-page":"28735","DOI":"10.1021\/acsnano.4c07615","article-title":"Machine learning elucidates design features of Plasmid deoxyribonucleic acid lipid nanoparticles for cell type-preferential transfection","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124429_bib12","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124429_bib13","doi-asserted-by":"crossref","first-page":"114177","DOI":"10.1016\/j.jconrel.2025.114177","article-title":"Adipocyte-selective mRNA lipid nanoparticles for cell programming with machine learning analysis","volume":"387","author":"Greco","year":"2025","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.biomaterials.2026.124429_bib14","doi-asserted-by":"crossref","first-page":"121339","DOI":"10.1016\/j.biomaterials.2021.121339","article-title":"In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift","volume":"281","author":"Kheirolomoom","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124429_bib15","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124429_bib16","article-title":"Lipid nanoparticles for engineering next generation CAR T cell immunotherapy","author":"Ang","year":"2025","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.biomaterials.2026.124429_bib17","article-title":"Nanoparticle targeting strategies for lipid and polymer-based gene delivery to immune cells in vivo","volume":"4","author":"Jain","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.biomaterials.2026.124429_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1562248","article-title":"Deciphering the deterministic role of TCR signaling in T cell fate determination","volume":"16","author":"Qin","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124429_bib19","series-title":"Mol. Biol. Cell","article-title":"Helper T cells and lymphocyte activation","author":"Alberts","year":"2002"},{"key":"10.1016\/j.biomaterials.2026.124429_bib20","first-page":"399","article-title":"Utilizing T-cell activation signals 1, 2 and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanoma","volume":"41","author":"Tavera","year":"2018","journal-title":"J. Immunother. Hagerstown Md 1997"},{"key":"10.1016\/j.biomaterials.2026.124429_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2026.100368","article-title":"Nanoscale artificial antigen-presenting cells reveal metabolic interventions modulate clonal composition of CD8+ T cells","author":"Choy","year":"2026","journal-title":"Cell Biomater"},{"key":"10.1016\/j.biomaterials.2026.124429_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124429_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154528","article-title":"Cytokine sustained delivery for cancer therapy; special focus on stem cell- and biomaterial- based delivery methods","volume":"247","author":"Mehralizadeh","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.biomaterials.2026.124429_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110134","article-title":"Diffusion-limited cytokine signaling in T cell populations","volume":"27","author":"Brunner","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.biomaterials.2026.124429_bib25","first-page":"604","article-title":"IL-7 immunotherapies: current applications and engineering opportunities, immunol","volume":"54","author":"Ariail","year":"2025","journal-title":"Invest"},{"key":"10.1016\/j.biomaterials.2026.124429_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319856121","article-title":"IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation","volume":"121","author":"Tilsed","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biomaterials.2026.124429_bib27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41551-025-01511-8","article-title":"Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level","volume":"9","author":"Kang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2026.124429_bib28","unstructured":"Spikevax\u00ae (COVID-19 Vaccine, mRNA) | Moderna, (n.d.). https:\/\/spikevaxpro.com (accessed September 22, 2025)."},{"key":"10.1016\/j.biomaterials.2026.124429_bib29","first-page":"403","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, N. Engl","volume":"384","author":"Baden","year":"2021","journal-title":"J. Med."},{"key":"10.1016\/j.biomaterials.2026.124429_bib30","doi-asserted-by":"crossref","first-page":"15729","DOI":"10.1021\/acsnano.4c02341","article-title":"In lipid nanoparticles","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124429_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124429_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz1722","article-title":"Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion","volume":"12","author":"Jain","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124429_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jconrel.2023.02.008","article-title":"Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing","volume":"355","author":"Onuma","year":"2023","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biomaterials.2026.124429_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124429_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/bloodadvances.2019001287","article-title":"Chimeric antigen receptor\u2013T cells with cytokine neutralizing capacity","volume":"4","author":"Tan","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.biomaterials.2026.124429_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124429_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809158","article-title":"In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124429_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1671761","article-title":"In vivo generated human CAR T cells eradicate tumor cells","volume":"8","author":"Agarwal","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biomaterials.2026.124429_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124429_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/acs.bioconjchem.4c00038","article-title":"Targeting strategies for site-specific mRNA delivery","volume":"35","author":"Di","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2026.124429_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady5579","article-title":"A multistep platform identifies spleen-tropic lipid nanoparticles for in vivo T cell\u2013targeted delivery of gene-editing proteins,","volume":"11","author":"Lu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124429_bib42","first-page":"1","article-title":"Preparation of targeted lipid nanoparticles for precision nucleic acid delivery","author":"Geisler","year":"2026","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2026.124429_bib43","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2009-10-246876","article-title":"IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7R\u03b1 in T cells","volume":"115","author":"Henriques","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2026.124429_bib44","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.3324\/haematol.2019.232959","article-title":"Kinetics of cytokine receptor internalization under steady-state conditions affects growth of neighboring blood cells","volume":"105","author":"Nagamachi","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.biomaterials.2026.124429_bib45","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s44286-024-00116-3","article-title":"Tuning extracellular fluid viscosity to enhance transfection efficiency","volume":"1","author":"Ma","year":"2024","journal-title":"Nat. Chem. Eng."},{"key":"10.1016\/j.biomaterials.2026.124429_bib46","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1182\/blood-2012-08-449215","article-title":"IL-7\/anti\u2013IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R","volume":"121","author":"Martin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2026.124429_bib47","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.actbio.2025.05.066","article-title":"Recombinant cytokine bioconjugates with degradable nanogel substrates for macrophage immunotherapy","volume":"201","author":"Ajeeb","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124429_bib48","article-title":"In Vivo stimulation of therapeutic antigen-specific T cells in an artificial lymph node matrix","volume":"36","author":"Livingston","year":"2024","journal-title":"Adv. Mater. Deerfield Beach Fla"},{"key":"10.1016\/j.biomaterials.2026.124429_bib49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/jfb14110533","article-title":"Aligned collagen sponges with tunable pore size for skeletal muscle tissue regeneration","volume":"14","author":"Kozan","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.biomaterials.2026.124429_bib50","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41467-025-61299-8","article-title":"An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapy","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124429_bib51","article-title":"Class II peptide-major histocompatibility complex lipid nanoparticles enable in vivo mRNA delivery to antigen-specific CD4+ T cells","author":"Choy","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124429_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113687","article-title":"Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery","volume":"382","author":"Suzuki","year":"2025","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.biomaterials.2026.124429_bib53","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124429_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713364","article-title":"CAR-NK cells generated with mRNA-LNPs kill tumor target cells in vitro and in vivo","volume":"24","author":"Golubovskaya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124429_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01124","article-title":"The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy,","volume":"8","author":"Paul","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124429_bib56","volume":"10","author":"Heinze","year":"2019","journal-title":"Immunol. Ser."},{"key":"10.1016\/j.biomaterials.2026.124429_bib57","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.biomaterials.2026.124429_bib58","article-title":"One-component cationic lipids for systemic mRNA delivery to splenic T cells","volume":"63","author":"Zhang","year":"2024","journal-title":"Angew. Chem. Int. Ed"},{"key":"10.1016\/j.biomaterials.2026.124429_bib59","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41589-023-01313-6","article-title":"Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds","volume":"19","author":"Yang","year":"2023","journal-title":"Nat. Chem. Biol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:46:40Z","timestamp":1787777200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":59,"alternative-id":["S0142961226004539"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124429","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124429"}}